Given that LARS2 is a mitochondrial leucyl-tRNA synthetase involved in mitochondrial protein synthesis and energy metabolism, its overexpression in COAD may contribute to an altered tumor metabolic environment, which in turn affects CD8+ T cell function. The gene discussed is CD8A; the disease is neoplasm.